Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 11, 2008, Pages 1196-1204

  Pedruzzi, Paola A G ^a   Kowalski, Luiz P ^b   Nishimoto, Ines N ^b   Oliveira, Benedito V ^a   Tironi, Fabio ^a   Ramos, Gyl H A ^a  

^a Hospital Erasto Gaertner   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RATING SCALE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; WEIGHT REDUCTION; ZUBROD SCALE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 56649115914     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.11.1196     Document Type: Article

References (26)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114(5):806-816.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43-66.
3. Burke HB, Henson DE. The American Joint Committee on Cancer: criteria for prognostic factors and for an enhanced prognostic system. Cancer. 1993;72(10):3131-3135.
4. Berg H. Die prognostische relevanz dês TNM-systems fur oropharynxkarzinome. Tumordiagn Ther. 1992;13:171-177.
5. Jones GW, Browman G, Goodyear M, Marcellus D, Hodson DI. Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer. Head Neck. 1993;15(6):497-503.
6. Snyderman CH, Wagner RL. Superiority of the T and N integer score (TANIS) staging for squamous cell carcinoma of the oral cavity. Otolaryngol Head Neck Surg. 1995;112(6):691-694.
7. Hart AA, Mak-Kregar S, Hilgers FJ, et al. The importance of correct stage grouping in oncology: results of a nationwide study of oropharyngeal carcinoma in the Netherlands. Cancer. 1995;75(11):2656-2662.
8. Kiricuta IC. The importance of correct stage grouping in oncology: results of a nationwide study of oropharyngeal carcinoma in the Netherlands. Cancer. 1996;77(3):587-590.
9. Hall SF, Groome PA, Rothwell D, Dixon PF. Using TNM staging to predict survival in patients with squamous cell carcinoma of head and neck. Head Neck. 1999;21(1):30-38.
10. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 1996;77(5):834-842.
11. Pugliano FA, Piccirillo JF, Zequeira MR, Fredrickson JM, Perez CA, Simpson JR. Symptoms as an index of biologic behavior in head and neck cancer. Otolaryngol Head Neck Surg. 1999;120(3):380-386.
12. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope. 2000;110(4):593-602.
13. Ribeiro KCB, Kowalski LP, Latorre MRDO. Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg. 2000;126(9):1079-1085.
14. Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis. 2003;9(3):112-118.
15. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx: five-year survival rates. Ann Otol Rhinol Laryngol. 1994;103(2):83-92.
16. Denis F, Garand P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22(1):69-76.
17. American Joint Committee on Cancer. Purposes and principles of staging. In: AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997:3-9.
18. Patel SG, Shah JP. Tumors of the oropharynx. In: Shah JP, ed. Cancer of the Head and Neck (ACS Atlas of Clinical Oncology). Hamilton, ON: BC Decker Inc; 2001:127-144.
19. Carvalho AL, Ikeda MK, Magrin J, Kowalski LP. Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution. Oral Oncol. 2004;40(1):71-76.
20. Kovács AF, Mose S, Bottcher HD, Bitter K. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol. 2005;181(1):26-34.
21. Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx an analysis of treatment results in 289 consecutive patients. Acta Oncol. 2000;39(8):985-994.
22. Mick R, Vokes EE, Weichselbaum RR, Panje WR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg. 1991;105(1):62-73.
23. Sundaram K, Schwartz J, Har-El G, Lucente F. Carcinoma of the oropharynx: factors affecting outcome. Laryngoscope. 2005;115(9):1536-1542.
24. Miguel RE, Villa LL, Cordeiro AC, Prado JC, Sobrinho JS, Kowalski LP. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg. 1998;176(5):428-429.
25. Schlecht NF, Pintos J, Kowalski LP, Franco EL. Effect of type of alcoholic beverage on the risks of upper aerodigestive tract cancers in Brazil. Cancer Causes Control. 2001;12(7):579-587.
26. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355(9208):949-955.